US2019151392A1PendingUtilityA1

Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder

Assignee: SEIPEL TRACEY ANNEPriority: Dec 23, 2011Filed: Jan 25, 2019Published: May 23, 2019
Est. expiryDec 23, 2031(~5.4 yrs left)· nominal 20-yr term from priority
A61P 13/10A61P 13/02A61K 36/11A61K 36/12A61K 36/54A61K 36/185
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided in one embodiment is an herbal compositions for the prevention or treatment of urogenital system disorders including urinary incontinence, overactive bladder, enuresis, benign prostatic hyperplasia, nocturia, cystitis, urinary calculi, or a urinary tract infection. Specifically one embodiment provides compositions that contain Crateva nurvala, Equisetum arvense, and Lindera aggregate and methods of use thereof.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating or reducing the symptoms of urinary incontinence or overactive bladder, comprising administering an effective amount to a subject in need thereof of an herb-containing composition, comprising:
 a  Crateva nurvala  extract preparation;   (ii) an  Equisetum arvense  extract preparation; and   (iii) a  Lindera aggregata  extract preparation;
 wherein the herb-containing composition is formulated as an oral dosage unit whereby the oral dosage unit is in a form selected from a tablet, capsule or caplet. 
   
     
     
         2 . The method of claim  13 , wherein the treatment results in a reduction in at least one of (i) urinary incontinence and (ii) overactive bladder symptom after about two weeks. 
     
     
         3 . The method of claim  13 , wherein the treatment results in a reduction in at least one of (i) urinary incontinence and (ii) overactive bladder symptom after about one month. 
     
     
         4 . The method of claim  13 , wherein at least one of the extracts is prepared by a process comprising:
 extracting the  Crateva nurvala  preparation from  Crateva nurvala  stem/bark at an extract ratio of between about 25 and 35;   (ii) extracting the  Equisetum arvense  extract preparation from  Equisetum arvense  stem at an exact ratio of about 10; and   (iii) extracting the  Lindera aggregata  preparation from  Lindera aggregata  root at an extract ratio of about 10.

Join the waitlist — get patent alerts

Track US2019151392A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.